Tarsus Pharmaceuticals (TARS) Earnings Date & Reports
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TARS is expected to report earnings to fall 71.40% to -8 cents per share on March 16
Q4'25
Est.
$-0.09
Q3'25
Beat
by $0.05
Q2'25
Missed
by $0.10
Q1'25
Beat
by $0.15
Q4'24
Beat
by $0.17
The last earnings report on November 04 showed earnings per share of -30 cents, beating the estimate of -34 cents. With 354.55K shares outstanding, the current market capitalization sits at 3.07B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TARS showed earnings on November 04, 2025. You can read more about the earnings report here.